Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic Stroke (RECOMBINE)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Rehabilitation after stroke improves motor functions by promoting plastic changes however, after completing standard rehabilitation, 50-60% of patients still exhibit some degree of motor impairment and require at least partial assistance in activities of day living. Therefore, the exploration of other approaches to promote recovery is compulsory. Non invasive brain stimulation and motor rehabilitation are thought to share similar mechanisms in inducing neuroplastic changes in the human cortex and an emerging field of research is focusing on the possibility of coupling both therapies in order to achieve an additive effect and improve outcome.
We hypothesize that coupling bihemispheric transcranial direct current stimulation (tDCS) with simultaneous physical/occupational therapy in the subacute phase of ischemic stroke patients may improve upper limb motor recovery in humans.
This is a randomized, controlled, double blind, cross-over, multicentre, clinical trial. Thirty-six ischemic stroke patients in the subacute phase will be recruited in three centers of neurorehabilitation in Switzerland. After stratification based on the Fugl-Meyer Assessment Upper Extremity according to the severity of the deficit, the patient will be randomized to receive besides standardized physical/occupational treatment according to the Impairment-Oriented Training, tDCS of themotor cortex (1.5 mA, 30 minutes) (group 1: 12 patients) or sham stimulation (without current) (group 2: 12 patients). After three weeks of treatment group 1 and 2 will cross-over and will be treated for other three weeks. Group 3 (12 patients) will receive routine physical/occupational treatment and sham tDCS for six weeks. Assessment will be performed before starting tDCS, at week 3, 6 and at 6 months. Outcome measures are the Fugl-Meyer Assessment Upper Extremity, the extended Barthel Index, the Ashworth scale, the Test of Upper Limb Apraxia (only baseline, week 6, month6), the grip strength evaluated by the Jamar Hydraulic Hand dynamometer. At baseline at week 6 and at month 6 depression will be assessed by the Hamilton depression Rating Scale.
| Condition | Intervention |
|---|---|
|
First Ever Clinical Stroke Ischemic Stroke Subacute Phase Persistent Hemiparesis of Upper Extremity |
Procedure: transcranial direct current stimulation (tDCS) Procedure: Sham stimulation, then tDCS Procedure: Sham stimulation |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Investigator) |
| Official Title: | Rehabilitation Combined With Bihemispherictranscranial Direct Current Stimulation in Subacute Ischemic Stroke to Increase Upper Limb Motor Recovery, a Randomised, Controlled, Double-blind Study |
- Fugl-Meyer Assessment Upper Extremity [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]Investigator administered questionnaire
- Fugl-Meyer Assessment Upper Extremity [ Time Frame: 3 weeks ] [ Designated as safety issue: No ]Investigator administered questionnaire
- Fugl-Meyer Assessment Upper Extremity [ Time Frame: 6 months ] [ Designated as safety issue: No ]Investigator administered questionnaire
- Barthel Index [ Time Frame: 3 weeks ] [ Designated as safety issue: No ]Investigator administered questionnaire
- Barthel Index [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]Investigator administered questionnaire
- Barthel Index [ Time Frame: 6 months ] [ Designated as safety issue: No ]Investigator administered questionnaire
- Ashworth scale [ Time Frame: 3 weeks ] [ Designated as safety issue: No ]Investigator administered questionnaire
- Ashworth scale [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]Investigator administered questionnaire
- Ashworth scale [ Time Frame: 6 months ] [ Designated as safety issue: No ]Investigator administered questionnaire
- Test of Upper Limb Apraxia (TULIA) [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]investigator administered questionnaire
- Test of Upper Limb Apraxia (TULIA) [ Time Frame: 6 months ] [ Designated as safety issue: No ]investigator administered questionnaire
- Grip strength [ Time Frame: 3 weeks ] [ Designated as safety issue: No ]Jamar Hydraulic Hand dynamometer
- Grip strength [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]Jamar Hydraulic Hand dynamometer
- Grip strength [ Time Frame: 6 months ] [ Designated as safety issue: No ]Jamar Hydraulic Hand dynamometer
- Hamilton depression Rating scale [ Time Frame: 6 weeks ] [ Designated as safety issue: No ]Patient administered questionnaire
- Hamilton depression Rating scale [ Time Frame: 6 months ] [ Designated as safety issue: No ]Patient administered questionnaire
| Estimated Enrollment: | 36 |
| Study Start Date: | September 2012 |
| Estimated Study Completion Date: | October 2014 |
| Estimated Primary Completion Date: | April 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1 tDCS-Sham
tDC stimulation for 3 weeks, then cross-over to sham stimulation
|
Procedure: transcranial direct current stimulation (tDCS)
Anodal tDCS of the ipsilesional motor cortex and cathodal tDCS of contralesional motor cortex (1.5 mA, 30 minutes) for 15 days during three weeks, then sham stimulation for 30 seconds on 15 days during 3 weeks
|
|
Experimental: 2 Sham-tDCS
Sham stimulation for 3 weeks, then cross over to tDCS stimulation
|
Procedure: Sham stimulation, then tDCS
Sham stimulation for 30 seconds on 15 days during 3 weeks, then anodal tDCS of the ipsilesional motor cortex and cathodal tDCS of contralesional motor cortex (1.5 mA, 30 minutes) for 15 days during three weeks
|
|
Sham Comparator: 3 Sham-Sham
Treatment for 6 weeks daily with sham stimulation
|
Procedure: Sham stimulation
Sham stimulation for 30 seconds on 15 days during 6 weeks
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Ischemic lesions in the territory of middle cerebral artery subcortical or subcortical/cortical confirmed neuroimaging
- Inclusion must be in the sub-acute phase defined as within 2-4 weeks after stroke
- Persistent hemiparesis, indicated by a score of 1-3 on the motor arm item of the NIH Stroke Scale (NIHSS) (Brott et al. 1989) but wrist and finger movement is not required
- No UE injury or conditions that limited use prior to the stroke.
- The patient is >18 years old.
- The patient has subscribed the informed consent
Exclusion Criteria:
- History of epilepsy, brain tumor, major head trauma, learning disorder, severe cognitive impairment, drug or alcohol abuse, major psychiatric illness
- Use of medications that may lower seizure threshold (e.g., metronidazole, fluoroquinolones)
- Severe pain in the affected upper limb (>=8 on the shoulder item of the "joint pain during passive motion" of the Fugl-Meyer Assessment Upper Extremity)
- Further stroke or other significant medical complication during the study
- Evidence of severe leucoencephalopathy (grade IV according to the Fazeka's scale)
- Important aphasia that would impair the understanding and performance of the assessment scales
Contacts and Locations| Contact: Carlo Cereda, MD | +41 91 811 66 91 | Carlo.Cereda@eoc.ch |
| Contact: René Müri, MD | +41 31 632 30 83 | rene.mueri@insel.ch |
| Switzerland | |
| Universitätsspital Bern, Inselspital, Neuropsychologische Rehabilitation | Not yet recruiting |
| Bern, Switzerland, 3010 | |
| Contact: René Müri, MD +41 31 632 30 83 rene.mueri@insel.ch | |
| Principal Investigator: René Müri, MD | |
| Clinica Hildebrand, Centro di riabilitazione Brissago | Not yet recruiting |
| Brissago, Switzerland, 6614 | |
| Contact: Fabio M Conti, MD +41 91 786 86 86 f.conti@clinica-hildebrand.ch | |
| Principal Investigator: Fabio M Conti, MD | |
| HELIOS Klinik Zihlschlacht AG, Neurologisches Rehabilitationszentrum | Not yet recruiting |
| Zihlschlacht, Switzerland, 8588 | |
| Contact: Daniel Zutter, MD +41 71 424 30 02 daniel.zutter@helios-kliniken.ch | |
| Contact: Silke Neumann, MSc +41 71 424 37 39 s.neumann@helios-kliniken.ch | |
| Principal Investigator: Daniel Zutter, MD | |
| Sub-Investigator: Matthias Oechsner, MD | |
| Principal Investigator: | Carlo Cereda, MD | Ospedale Regionale di Lugano - Civico |
| Principal Investigator: | René Müri, MD | Universitätsspital Bern, Inselspital, Neuropsychologische Rehabilitation |
More Information
Additional Information:
Publications:
| Responsible Party: | Dr. med. Carlo Cereda, Capo clinica, Ospedale Civico, Lugano |
| ClinicalTrials.gov Identifier: | NCT01644929 History of Changes |
| Other Study ID Numbers: | EOC.NSI.11.02 |
| Study First Received: | July 17, 2012 |
| Last Updated: | August 2, 2012 |
| Health Authority: | Switzerland: Ethikkomission |
Keywords provided by Ospedale Civico, Lugano:
|
hemiparesis bihemispheric transcranial direct current stimulation ischemic stroke subacute |
rehabilitation physiotherapy ergotherapy |
Additional relevant MeSH terms:
|
Stroke Cerebral Infarction Paresis Ischemia Neurologic Manifestations Nervous System Diseases Signs and Symptoms Pathologic Processes |
Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases Vascular Diseases Cardiovascular Diseases Brain Infarction Brain Ischemia |
ClinicalTrials.gov processed this record on May 16, 2013